Foveal cone-photoreceptor integrity in aging macula disorder

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 5, 2008, Pages 2077-2081

  Kanis, Martijn J ^a   Wisse, Robert P L ^a   Berendschot, Tos T J M ^b   Van De Kraats, Jan ^a   Van Norren, Dirk ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN; VISUAL PIGMENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE; EYE FUNDUS; EYE MALFORMATION; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; OPTICAL DENSITY; PHOTORECEPTOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFLECTOMETRY; RETINA CONE; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; VISUAL SYSTEM; AGING; CLASSIFICATION; LIGHT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; RETINA MACULA DEGENERATION;

AGED; AGING; CONES (RETINA); FOVEA CENTRALIS; HUMANS; LIGHT; MACULAR DEGENERATION; MELANINS; MIDDLE AGED; RETINAL PIGMENTS;

EID: 44649157924     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1181     Document Type: Article

References (45)

1. Stiles WS, Crawford BH. The luminous efficiency of rays entering the eye pupil at different points. Proc R Soc Lond [Biol]. 1933; 112:428-450.
2. DeLint PJ, Berendschot TTJM, van Norren D. A comparison of the optical Stiles-Crawford effect and retinal densitometry in a clinical setting. Invest Ophthalmol Vis Sci. 1998;39(8):1519-1523.
3. de Jong PTVM. Mechanisms of disease: age-related macular degeneration. N Engl J Med. 2006;355(14):1474-1485.
4. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002;1(3):381-396.
5. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS Report No. 11. Arch Ophthalmol. 2003;121(11):1621-1624.
6. Wang JJ, Rochtchina E, Lee AJ, et al. Ten-year incidence and progression of age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology. 2007;114(1):92-98.
7. Miyazaki M, Kiyohara Y, Yoshida A, Iida M, Nose Y, Ishibashi T. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: The Hisayama Study. Invest Ophthalmol Vis Sci. 2005;46(6):1907-1910.
8. Klaver CC, Assink JJ, Wolfs RC, et al. Incidence and progression rates of age-related maculopathy. The Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42:2237-2241.
9. Klein R, Klein BEK, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy. Ophthalmology. 2002;109(10):1767-1779.
10. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44(10): 4481-4488.
11. Kanski JJ. Clinical Ophthalmology. Fifth ed. Edinburgh, UK: Butterworth-Heinemann; 2004.
12. Tolentino MJ, Miller S, Gaudio AR, Sandberg MA. Visual-field deficits in early age-related macular degeneration. Vision Res. 1994; 34(3):409-413.
13. Birch DG, Fish GE. Focal cone electroretinograms: aging and macular disease. Doc Ophthalmol. 1988;69(3):211-220.
14. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41(1):267-273.
15. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003;44(5): 2277-2283.
16. Scholl HPN, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Pho- topic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci. 2004;45(2):574-583.
17. Walter P, Widder RA, Luke C, Konigsfeld P, Brunner R. Electrophysiological abnormalities in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237(12):962-968.
18. Weiter JJ, Delori FC, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol. 1988;106(3):286-292.
19. Zagers NPA, van de Kraats J, Berendschot TTJM, van Norren D. Simultaneous measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl Opt. 2002;41(22):4686- 4696.
20. van de Kraats J, van Norren D. Modeling the directional and non-directional spectral reflection from the human fovea. J Biomed Opt. 2008;13(2):024010.
21. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age- related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39(5):367-374.
22. Hofman A, Grobbee DE, de Jong PTVM, Vandenouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403-422.
23. Kanis MJ, Berendschot TTJM, van Norren D. Influence of macular pigment and melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol. 2007;245(6):767-773.
24. Boekhoorn SS, Vingerling JR, Uitterlinden AG, et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci. 2007;48(3):1012-1017.
25. Health Council of the Netherlands, c.o.o.r. Optical radiation: health-based exposure limits for electromagnetic radiation in the wavelength region from 100 nanometer to 1 millimeter. The Hague, The Netherlands; 1993.
26. van de Kraats J, Berendschot TTJM, van Norren D. The pathways of light measured in fundus reflectometry. Vision Res. 1996; 36(15):2229-2247.
27. van de Kraats J, van Norren D. Optical density of the aging human ocular media in the visible and the UV. J Opt Soc Am A. 2007;24: 1842-1857.
28. Handelman GJ, Snodderly DM, Adler AJ, Russett MD, Dratz EA. Measurement of carotenoids in human and monkey retinas. Meth- odsEnzymol. 1992;213:220-230.
29. Zagers NPA, van Norren D. Absorption of the eye lens and macular pigment derived from the reflectance of cone photoreceptors. J Opt Soc Am A Opt Image Sci Vis. 2004;21(12):2257-2268.
30. Berendschot TTJM, Willemse-Assink JJM, Bastiaanse M, de Jong PTVM, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci. 2002;43(6):1928-1932.
31. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27(2):145-152.
32. Delori FC, Burns SA. Fundus reflectance and the measurement of crystalline lens density. J Opt Soc Am A. 1996;13(2):215-226.
33. Berendschot TTJM, van Norren D. On the age dependency of the macular pigment optical density. Exp Eye Res. 2005;81(5):602- 609.
34. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42(2):439-446.
35. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The POLA Study. Invest Ophthalmol Vis Sci. 2006;47(6):2329-2335.
36. Elsner AE, Burns SA, Weiter JJ. Cone photopigment in older subjects: decreased optical density in early age-related macular degeneration. J Opt Soc Am A Opt Image Sci Vis. 2002;19(1):215- 222.
37. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age- related macular degeneration. Invest Ophthalmol Vis Sci. 1996; 37(7):1236-1249.
38. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41(8):2015-2018.
39. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease Case-Control Study Group. JAMA. 1994; 272(18):1413-1420.
40. Jahn C, Wustemeyer H, Brinkmann C, Trautmann S, Mossner A, Wolf S. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol. 2005;243(3):222-227.
41. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25(6):674 - 685.
42. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257-293.
43. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 1999;117(9):1203-1210.
44. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106(6):1056-1065.
45. Klein R, Klein BEK, Marino EK, etal. Earlyage-relatedmaculopathy in the cardiovascular health study. Ophthalmology. 2003;110(1): 25-33.